ワイヤー図法を使用してマウスの腸間膜動脈の等尺性収縮力測定

Executive Industry Relevance

The wire myograph technique enables precise measurement of vascular smooth muscle contractility, supporting target validation and mechanistic de-risking in hypertension drug discovery. By providing quantitative, reproducible force measurements in disease-relevant mouse mesenteric arteries, the method enhances predictive confidence for screening novel relaxants and assessing therapeutic potential early in the discovery pipeline.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Interrogates therapeutic hypotheses by measuring isometric contraction in response to GPCR agonists, inhibitors, and depolarizing agents.
• Operational Value: Enables functional validation of vascular targets through dose-response analysis of compounds like neoliensinine.

Screening & Assay Development

• Scientific Value: Generates quantitative dependent variable measurements (force tension) for assessing compound potency and efficacy.
• Operational Value: Supports assay standardization and reproducibility via normalization procedures and multi-channel capability for parallel compound testing.

Translational & Preclinical Research

• Scientific Value: Uses disease-relevant mouse mesenteric artery to model human vascular pathophysiology and assess translational biomarker alignment.
• Operational Value: Maintains vessel viability for ≥4 hours, enabling time-consuming screening campaigns and repeated contractility challenges.

Pipeline & Workflow Integration

The method fits within the discovery continuum from target validation through lead identification, providing contractility data that informs go/no-go decisions prior to preclinical investment.

• Discovery Biology: Supports mechanistic de-risking by isolating vascular smooth muscle responses to specific stimuli like high-K+ solution.
• Screening: Enables reliable compound evaluation through cumulative dosing and stable sustained phase measurements.
• Analytics: Delivers quantitative force readouts that allow comparison of drug effects across concentrations and conditions.
• Translational Research: Connects early discovery to preclinical continuity by using genetically tractable mouse models of vascular disease.
• Enterprise Reuse: Establishes a reusable platform for assessing vascular function across multiple projects and therapeutic areas.

Operational & Enterprise Impact

• Scientific Value: Provides predictive confidence in target engagement and reduces mechanistic ambiguity in smooth muscle pharmacology.
• Operational Value: Ensures standardization, reproducibility, and scalability via wire mounting and normalization protocols.
• Strategic Value: Improves go/no-go decisions, capital efficiency, and reduces late-stage biological risk in hypertension programs.
• Portfolio Impact: Enables risk-adjusted prioritization of compounds based on dose-dependent relaxant effects in vascular tissue.

Implementation Considerations

• Requires expertise in vascular dissection, wire myograph operation, and solution preparation.
• Dependent on myograph chambers, force transducers, micrometers, and temperature-controlled perfusion systems.
• Necessitates cross-team standardization of dissection, mounting, and normalization procedures for reproducible results.
• Involves adaptation considerations when applying the technique to different vessel sizes or species.
• Limited by the need for isolated tissue segments and the technical challenge of wire insertion without endothelial damage.

Biopharma FAQs